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In the meantime, it is essential that doctors become more aware
of the risks of the sulfonylurea hypoglycemic drugs and use them
cautiously, when all other therapeutic options have been exhausted.
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Describing Patients With
Discordant Ventriculoarterial Connections
I congratulate Blume et al. (1) on the excellence of their analysis of
patients undergoing the arterial switch operation. I am surprised,
however, when they state that the larger part of their patient group
had “d-transposition,” without providing further definition of this
contentious term. Does this mean, for example, that they excluded
all those patients with complete transposition in which the aorta
was to the left, such as those with mirror-imaged atrial arrange-
ment (transposition {I,L,L})? And did they include those patients
with a congenitally corrected transposition who had right-sided
aortas, such as those with the transposition {I,D,D}? The group
from Boston should now describe the anatomy of their patients
with the same accuracy of analysis which they apply to their results.
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We thank Dr. Anderson for his comments. We agree with him
that the importance of anatomic accuracy cannot be overempha-
sized. We did not exclude, on the basis of the spatial relation of the
aortic valve relative to the pulmonary valve, any patient from the
analysis. In fact, the interrelations between the semilunar valves
were specified in the Results section of our report. Furthermore,
we specified that only one patient had transposition of the great
arteries with visceroatrial situs inversus (segmental anatomy
{I,L,L}), and that patient was included in the analysis. We also
specified that patients with physiologically corrected transposition
of the great arteries {S,L,L} were excluded.
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Coronary Endothelial
Dysfunction After Kawasaki Disease
Although the question addressed in the article by Yamakawa et al.
(1) is interesting, there are several issues to be discussed with
respect to the methods and interpretation of the results.
Study protocol. The dose–response curve of normal coronary
arteries to acetylcholine (ACh) in their study is inconsistent with
previously established pharmacologic properties of coronary arter-
ies, on the basis of in vivo and ex vivo data in humans (including
children) and animals (2,3). Although ACh, in fact, dilated normal
epicardial coronary arteries only at high estimated concentrations
(3.0 to 6.0 mmol/liter, estimated final blood concentrations) in
their study, it has been established that ACh does so in a
dose-dependent manner at 0.01 to 1.0 mmol/liter, at which level
the contribution of nitric oxide to ACh-induced response has been
demonstrated (2,3). This difference might be due to the short
infusion time of ACh (30 s) in their study, as compared with 2 to
3 min in other studies. What could be the mechanism of the
ACh-induced vasodilation at 3.0 to 6.0 mmol/liter, but not at 1.0
mmol/liter? In addition, the dose of ACh could be individualized
when it is administered into either right or left coronary arteries in
children of different ages. Because Yamakawa et al. (1) showed
ACh-elicited paradoxic vasoconstriction at 10.0 mmol/liter, the
relatively narrow range of effective ACh concentrations, as com-
pared with those in previous reports, might in fact have produced
highly variable responses to ACh.
Analysis of coronary angiogram. Although Yamakawa et al.
concluded that normal coronary arteries but not regressed aneu-
rysm exhibit a normal ACh response in patients with Kawasaki
disease (KD), the angiograms could be investigated more cau-
tiously. They showed in Figure 3 that normal coronary arteries
after KD (left main coronary artery and distal portion of the left
circumflex artery [LCx]) dilated in response to ACh, whereas the
regressed aneurysm (proximal portion of the left anterior descend-
ing coronary artery [LAD]) constricted. Readers might observe,
however, that other segments (proximal portion of the LCx and
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distal portion of the LAD) in normal coronary arteries on the same
angiogram, in fact, seem to constrict without aneurysm, suggesting
that normal coronary arteries after KD also exhibit impaired
ACh-induced vasodilation in their protocol. In other words, even
the proximal portion of the LAD could constrict due to only the
history of KD, without the effect of aneurysm. The cause of
segmentally heterogeneous ACh responses is immediately un-
known. To demonstrate the association between aneurysm or
history of KD and ACh responses, specific diameter-matched and
corresponding segments should be compared among risk factor–
matched groups (2–5). Although Yamakawa et al. tried to compare
each segment between study groups, they only referred to the
“trend” of the difference, not the statistical difference in each
segment between study groups. In addition, comparable ACh-
induced vascular responses among different types of lesions, as
evaluated in multiple segments of patients in their report, would
not preclude the possibility that some susceptible segments with-
out aneurysms in KD groups exhibit abnormal ACh responses, as
shown in our report (3).
Interpretation of the results. Although Yamakawa et al. showed
impaired ACh-induced vasodilation in regressed aneurysm, it
might not be concluded that “endothelial function” is impaired in
these lesions, unless normal responses to an endothelium-
independent vasodilator are shown (2,3). In addition, the high
concentration of ACh, as used in their protocol, could elicit a
stronger “direct” vasoconstrictor response in the disease state,
which could have been misinterpreted as representing impaired
endothelial function (2). Accordingly, a more accurate conclusion
would be that “ACh-induced vasodilation” is impaired late after
KD.
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We appreciate the kind comments of Dr. Mitani regarding our
report and for sharing their experiences with us. We agree with
him that the adequate dosage of acetylcholine (ACh) required to
assess vascular function is uncertain for children. Thus, we pre-
liminarily studied the effects of different doses (5, 15, 30 and
50 mg) in a normal coronary artery and in regressed coronary
aneurysms after Kawasaki disease (KD) in four children. If we used
50 mg of ACh, the normal coronary artery became constricted, and
if 5 mg was used, the normal coronary artery did not dilate. When
we used 15 mg and 30 mg of ACh, significant dilation was observed
in the normal coronary arteries, and vasoconstriction appeared in
the regressed aneurysms. Thus, we chose a lower dose of 15 mg of
ACh in this study. Thus, 15 mg of ACh chloride was diluted in 5
ml of warm 0.9% saline solution (to produce a coronary blood
concentration of ;3.0 3 1026 mol/liter) and was infused into the
left or right coronary artery (LCA or RCA) over 30 s. In addition,
in the other study in question, a similar dose of ACh was used to
assess endothelium-dependent vasomotor function (2).
In our study, we measured normal sites where coronary aneu-
rysms had not developed to the acute stage and also demonstrated
normal findings at follow-up coronary angiography. We chose
these sites to include coronary segments located at least 10 mm
from the site of previous aneurysms to eliminate the effects of
vasoconstriction or vasodilation of other sites, as shown in Figure
3 in our article. The distal portion of the left anterior descending
coronary artery (LAD) seems to constrict from reducing the
proximal coronary flow caused by vasoconstriction of the distal
portion of this artery (Fig. 3). In addition, there was no significant
difference in the ACh responses between the LCA (11.2 6 6.3%)
and RCA (13.1 6 8%) (p 5 NS) in our control subjects.
Mitani et al. (3) have reported that constriction of a normal
region of the coronary artery after KD was constricted with ACh
infusion. However, several differences existed between our study
and their study. The interval between KD onset and the time of
their investigation was shorter than that in our study (3). Patho-
logic studies have demonstrated that infiltration by inflammatory
cells can occur in the coronary artery, even within six months after
the acute phase of KD (4,5). We studied only patients with KD
with an interval .10 years after the onset of KD to eliminate any
direct effects of acute KD vasculitis. In addition, their patients did
not have a complete normal coronary artery at the acute stage;
instead, they had only a normal LAD. In contrast, in our new
study, we investigated the vascular function of the coronary artery
using an intracoronary infusion of ACh chloride and isosorbide
dinitrate (ISDN) in five patients with KD who had a completely
normal first coronary angiogram (6). The patients with a normal
coronary artery after KD were not significantly different, in their
response to either ACh or ISDN infusion, from the control subjects.
These findings suggest that such coronary arteries had normal
function of the endothelium and smooth muscle even over the long
term. On the basis of our studies (1,6,7), we conclude that patients
with long-term persistent coronary aneurysms and regressed coronary
aneurysms after KD have vascular dysfunction. These patients should
be counseled to avoid potential risk factors for atherosclerosis and that
long-term follow-up is needed into adulthood.
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